BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6289311)

  • 1. A unique cell-surface protein phenotype distinguishes human small-cell from non-small-cell lung cancer.
    Baylin SB; Gazdar AF; Minna JD; Bernal SD; Shaper JH
    Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4650-4. PubMed ID: 6289311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of cell surface proteins delineates a differentiation pathway linking endocrine and nonendocrine human lung cancers.
    Goodwin G; Shaper JH; Abeloff MD; Mendelsohn G; Baylin SB
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3807-11. PubMed ID: 6304739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
    Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI
    Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoskeleton-associated proteins of human lung cancer cells.
    Bernal SD; Baylin SB; Shaper JH; Gazdar AF; Chen LB
    Cancer Res; 1983 Apr; 43(4):1798-808. PubMed ID: 6299529
    [No Abstract]   [Full Text] [Related]  

  • 5. Heterogeneity of a labeled tumor surface protein from a murine lung carcinoma demonstrated by two-dimensional electrophoresis.
    Eisinger RW; Kennel SJ
    Cancer Res; 1981 Mar; 41(3):877-81. PubMed ID: 7459873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-glycoprotein patterns of established human lung cancer cell lines and primary cultures.
    Bergh J; Nilsson K
    Anticancer Res; 1985; 5(4):323-8. PubMed ID: 2994548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated membrane sialoglycoprotein on human small cell lung carcinoma identified by the IgG2a monoclonal antibody SWA20.
    Waibel R; O'Hara CJ; Smith A; Stahel RA
    Cancer Res; 1988 Aug; 48(15):4318-23. PubMed ID: 2839290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paranuclear blue inclusions in metastatic undifferentiated small cell carcinoma in the bone marrow.
    Wittchow R; Laszewski M; Walker W; Dick F
    Mod Pathol; 1992 Sep; 5(5):555-8. PubMed ID: 1285355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of human lung cancer cells in culture: a potential model for studying molecular determinants of tumor progression and metastasis.
    Baylin SB; Jackson RH; Lennarz W; Shaper JH
    Symp Fundam Cancer Res; 1983; 36():281-91. PubMed ID: 6089293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane antigen in small cell carcinoma of the lung defined by monoclonal antibody SM1.
    Bernal SD; Speak JA
    Cancer Res; 1984 Jan; 44(1):265-70. PubMed ID: 6317170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of intermediate filaments in established human lung cancer cell lines. An indicator of differentiation and derivation.
    Bergh J; Nilsson K; Dahl D; Andersson L; Virtanen I; Lehto VP
    Lab Invest; 1984 Sep; 51(3):307-16. PubMed ID: 6206304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoskeletal differences between human neuroendocrine tumors: a cytoskeletal protein of molecular weight 46,000 distinguishes cutaneous from pulmonary neuroendocrine neoplasms.
    Moll R; Franke WW
    Differentiation; 1985; 30(2):165-75. PubMed ID: 3007249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of L-dopa decarboxylase and diamine oxidase (histaminase) in human lung cancers and decarboxylase as a marker for small (oat) cell cancer in cell culture.
    Baylin SB; Abeloff MD; Goodwin G; Carney DN; Gazdar AF
    Cancer Res; 1980 Jun; 40(6):1990-4. PubMed ID: 6245807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface glycoprotein patterns of cell lines derived from human small cell carcinoma of the lung.
    Bergh J; Nilsson K; Cate CC; Pettengill OS; Sorenson GD
    Acta Pathol Microbiol Immunol Scand A; 1983 Jan; 91(1):9-15. PubMed ID: 6299058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrin expression in neuroblastoma cells.
    Goodman SR; Zagon IS; Coleman DB; McLaughlin PJ
    Brain Res Bull; 1986 May; 16(5):597-602. PubMed ID: 2427173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin in human small cell lung carcinoma.
    Goedert M; Reeve JG; Emson PC; Bleehen NM
    Br J Cancer; 1984 Aug; 50(2):179-83. PubMed ID: 6087865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
    Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K
    Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of cell lines from human small cell and large cell carcinomas of the lung.
    Bergh J; Nilsson K; Ekman R; Giovanella B
    Acta Pathol Microbiol Immunol Scand A; 1985 May; 93(3):133-47. PubMed ID: 2990154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine-related biochemistry in the spectrum of human lung cancers.
    Baylin SB; Jackson RD; Goodwin G; Gazdar AF
    Exp Lung Res; 1982 Nov; 3(3-4):209-23. PubMed ID: 6132808
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
    Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A
    J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.